Company / R&D per Share
Aquestive Therapeutics, Inc. R&D per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$0.19
FY2025
5-year range
$0.19 / $0.58
FY2021-FY2025
Trend
-36.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
R&D per Share has fluctuated over the past 8 years, ranging from $0.19 in FY2025 to $0.93 in FY2019.
Based on SEC 10-K filings.
0.19 in FY2025 with a 5-year CAGR of -21.0%.
Declined from $0.24 to $0.19 over the past 2 years.
R&D per Share over time
Growth rates
- 3-Year CAGR
- -23.7%
- 5-Year CAGR
- -21.0%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, r&d per share decreased 36.4% year-over-year.
- Peak r&d per share was recorded in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -3.08 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.19 | -36.4% |
| FY2024 | $0.30 | +23.8% |
| FY2023 | $0.24 | -43.6% |
| FY2022 | $0.42 | -26.3% |
| FY2021 | $0.58 | -6.2% |
| FY2020 | $0.61 | -33.8% |
| FY2019 | $0.93 | +4.4% |
| FY2018 | $0.89 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026